|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM365543411 |
| 003 |
DE-627 |
| 005 |
20240304232112.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/jcc.27273
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1316.xml
|
| 035 |
|
|
|a (DE-627)NLM365543411
|
| 035 |
|
|
|a (NLM)38063457
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Khan, Muhammad Sanwal
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Computational investigation of pyrazinamide drugs and its transition metal complexes using a DFT approach
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 04.03.2024
|
| 500 |
|
|
|a Date Revised 04.03.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley Periodicals LLC.
|
| 520 |
|
|
|a Pyrazinamide, an antituberculosis but documented toxic drug, is subjected to computational investigation along with the metal complexes via a DFT approach to predict the structure-activity and structure-toxicity relationship. 6-31G(d,p) basis set was used for Zn, Ni, Mn, Fe, and Co, while the SDD basis set was applied to Cu, Cr, Cd, and Hg. Several reactivity parameters and charge distribution were calculated and the reactivity profile was estimated. The complexes were found to be soft and polarizable which could be responsible for their binding with bacterial targets to inhibit their growth. In contrast, pyrazinamide which is found to be hard among all is susceptible to being toxic. Moreover, the electronegative nature of the complexes can endow them with a better antibacterial effect. Since metal complexes have been found to be less toxic and more biologically interactive by computational methods, they can be employed as potent drugs for the cure of tuberculosis
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a DFT
|
| 650 |
|
4 |
|a drug scoring
|
| 650 |
|
4 |
|a geometry optimization
|
| 650 |
|
4 |
|a pyrazinamide metal complexes
|
| 650 |
|
4 |
|a reactivity profile
|
| 650 |
|
7 |
|a Pyrazinamide
|2 NLM
|
| 650 |
|
7 |
|a 2KNI5N06TI
|2 NLM
|
| 650 |
|
7 |
|a Coordination Complexes
|2 NLM
|
| 650 |
|
7 |
|a Mercury
|2 NLM
|
| 650 |
|
7 |
|a FXS1BY2PGL
|2 NLM
|
| 650 |
|
7 |
|a Anti-Bacterial Agents
|2 NLM
|
| 700 |
1 |
|
|a Maha, Nasir
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Riaz, Maira
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yasmin, Tahira
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Irfan, Ahmad
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Basra, Muhammad Asim Raza
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Journal of computational chemistry
|d 1984
|g 45(2024), 10 vom: 15. März, Seite 622-632
|w (DE-627)NLM098138448
|x 1096-987X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:45
|g year:2024
|g number:10
|g day:15
|g month:03
|g pages:622-632
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/jcc.27273
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 45
|j 2024
|e 10
|b 15
|c 03
|h 622-632
|